1. Home
  2. PASG vs MYND Comparison

PASG vs MYND Comparison

Compare PASG & MYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PASG
  • MYND
  • Stock Information
  • Founded
  • PASG 2017
  • MYND 1998
  • Country
  • PASG United States
  • MYND United States
  • Employees
  • PASG N/A
  • MYND N/A
  • Industry
  • PASG Biotechnology: Pharmaceutical Preparations
  • MYND Other Consumer Services
  • Sector
  • PASG Health Care
  • MYND Real Estate
  • Exchange
  • PASG Nasdaq
  • MYND Nasdaq
  • Market Cap
  • PASG 27.6M
  • MYND 28.3M
  • IPO Year
  • PASG 2020
  • MYND 2017
  • Fundamental
  • Price
  • PASG $8.24
  • MYND $0.62
  • Analyst Decision
  • PASG Strong Buy
  • MYND
  • Analyst Count
  • PASG 4
  • MYND 0
  • Target Price
  • PASG $34.50
  • MYND N/A
  • AVG Volume (30 Days)
  • PASG 41.6K
  • MYND 17.8K
  • Earning Date
  • PASG 11-10-2025
  • MYND 08-27-2025
  • Dividend Yield
  • PASG N/A
  • MYND N/A
  • EPS Growth
  • PASG N/A
  • MYND N/A
  • EPS
  • PASG N/A
  • MYND N/A
  • Revenue
  • PASG N/A
  • MYND $209,800,000.00
  • Revenue This Year
  • PASG N/A
  • MYND N/A
  • Revenue Next Year
  • PASG N/A
  • MYND N/A
  • P/E Ratio
  • PASG N/A
  • MYND N/A
  • Revenue Growth
  • PASG N/A
  • MYND N/A
  • 52 Week Low
  • PASG $5.12
  • MYND $0.50
  • 52 Week High
  • PASG $26.60
  • MYND $3.89
  • Technical
  • Relative Strength Index (RSI)
  • PASG 53.96
  • MYND 45.53
  • Support Level
  • PASG $7.13
  • MYND $0.52
  • Resistance Level
  • PASG $9.24
  • MYND $0.63
  • Average True Range (ATR)
  • PASG 0.89
  • MYND 0.08
  • MACD
  • PASG 0.03
  • MYND 0.01
  • Stochastic Oscillator
  • PASG 57.09
  • MYND 63.65

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

Share on Social Networks: